We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.2B
AUM Growth
-$292M
Cap. Flow
-$360M
Cap. Flow %
-29.98%
Top 10 Hldgs %
36.37%
Holding
162
New
39
Increased
27
Reduced
54
Closed
29

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$33.1M
2
AAPL icon
Apple
AAPL
+$31.3M
3
DHI icon
D.R. Horton
DHI
+$27M
4
YELP icon
Yelp
YELP
+$26.6M
5
AVGO icon
Broadcom
AVGO
+$21.7M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Financials 21.79%
3 Consumer Discretionary 17.91%
4 Healthcare 16.66%
5 Real Estate 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$130B
$7.87M 0.66%
128,360
-67,600
-34% -$4.23M
PFE icon
52
Pfizer
PFE
$157B
$7.63M 0.64%
222,078
-159,154
-42% -$5.43M
EPI icon
53
WisdomTree India Earnings Fund ETF
EPI
$1.95B
$6.83M 0.57%
245,200
+24,900
+11% +$664K
CHCT
54
Community Healthcare Trust
CHCT
$420M
$6.48M 0.54%
230,500
NOW icon
55
ServiceNow
NOW
$147B
$6.38M 0.53%
+244,500
New +$6.08M
LKFT
56
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$6.23M 0.52%
66,453
-6,000
-8% -$568K
SCI icon
57
Service Corp International
SCI
$11.1B
$6.12M 0.51%
163,868
-35,800
-18% -$1.28M
TPH
58
DELISTED
Tri Pointe Homes
TPH
$6.11M 0.51%
340,771
-156,500
-31% -$2.64M
OPTU
59
Optimum Communications Inc
OPTU
$377M
$6.1M 0.51%
287,300
+108,600
+61% +$2.4M
BIVV
60
DELISTED
Bioverativ Inc. Common Stock
BIVV
$5.86M 0.49%
108,600
-62,300
-36% -$3.41M
WVE icon
61
Wave Life Sciences
WVE
$879M
$5.59M 0.47%
159,403
-49,300
-24% -$1.44M
BZUN
62
Baozun
BZUN
$159M
$5.39M 0.45%
170,800
-20,100
-11% -$649K
ORBK
63
DELISTED
Orbotech Ltd
ORBK
$5.14M 0.43%
102,400
+48,339
+89% +$2.35M
XRN
64
Chiron Real Estate Inc
XRN
$478M
$5.13M 0.43%
125,000
CGBD icon
65
Carlyle Secured Lending
CGBD
$789M
$5.02M 0.42%
+250,700
New +$4.63M
NXTM
66
DELISTED
NxStage Medical Inc.
NXTM
$4.99M 0.42%
+205,900
New +$5.42M
DERM
67
DELISTED
Dermira, Inc.
DERM
$4.92M 0.41%
177,085
-36,300
-17% -$963K
BEN icon
68
Franklin Templeton
BEN
$16.9B
$4.84M 0.4%
111,600
-104,000
-48% -$4.5M
CORV
69
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$4.13M 0.34%
2,667,585
-211,400
-7% -$340K
BMRN icon
70
BioMarin Pharmaceuticals
BMRN
$12.5B
$3.52M 0.29%
39,445
-9,200
-19% -$800K
KURA icon
71
Kura Oncology
KURA
$1.01B
$3.25M 0.27%
212,761
-12,100
-5% -$178K
TAL icon
72
TAL Education Group
TAL
$6.52B
$3.01M 0.25%
+101,200
New +$3.08M
INDA icon
73
iShares MSCI India ETF
INDA
$6.45B
$2.52M 0.21%
69,900
DOC
74
DELISTED
PHYSICIANS REALTY TRUST
DOC
$2.45M 0.2%
136,000
BSX icon
75
Boston Scientific
BSX
$63.6B
$2.36M 0.2%
95,300
-162,100
-63% -$4.47M

Similar funds

Clough Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Clough Capital Partners held 162 positions worth $1.2B, down 20% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners withdrew a net $360M in Q4 2017, closing 29 positions and reducing 54 holdings. Its most notable exit was Yelp, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Clough Capital Partners opened a new position in Apellis Pharmaceuticals worth $19.7M.

  • Clough Capital Partners's largest Q4 2017 buy was Apellis Pharmaceuticals: 917,116 shares worth $19.7M.
  • Clough Capital Partners added most to Wayfair in Q4 2017, an estimated $8.01M increase.
  • Clough Capital Partners's biggest Q4 2017 reduction was Lam Research, cutting an estimated $33.1M.
  • Clough Capital Partners fully exited Yelp in Q4 2017, selling an estimated $26.6M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $1.2B portfolio in Q4 2017.
  • Clough Capital Partners opened 39 new positions and closed 29 in Q4 2017.
  • Clough Capital Partners's portfolio value fell 20% quarter-over-quarter to $1.2B.

Based on Clough Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.